An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis

Ben Roediger1, Quintin Lee1, Shweta Tikoo1

  • 1Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia.

Cell
|September 18, 2018
PubMed

Insights

A novel parvovirus, mouse kidney parvovirus (MKPV), has been identified as the cause of a long-standing kidney disease in lab mice. This discovery offers a new model for studying kidney fibrosis and human chronic kidney disease.

Area of Science:

  • Veterinary Pathology
  • Virology
  • Genomics

Background:

  • A spontaneous nephropathy with intranuclear inclusions has been observed in laboratory mice for over 40 years.
  • The etiology of this kidney disease has remained elusive, though increased severity in immunodeficient mice suggested an infectious cause.

Purpose of the Study:

  • To identify the causative agent of the spontaneous nephropathy in laboratory mice.
  • To characterize the identified pathogen and the resulting kidney disease.
  • To establish a new model for studying tubulointerstitial fibrosis.

Main Methods:

  • Metagenomic analysis was employed to identify the infectious agent.
  • Histopathological examination and clinical course analysis were performed.
  • The distribution and transmission routes of the virus were investigated.

Main Results:

  • Metagenomics identified an atypical parvovirus, termed mouse kidney parvovirus (MKPV), as the causative agent.
  • MKPV is widespread in Australian and North American animal facilities, transmitted via fecal-oral or urinary-oral routes.
  • The study detailed a progressive pathology from inclusions to renal failure, controlled by the adaptive immune system.

Conclusions:

  • Mouse kidney parvovirus (MKPV) is identified as the cause of a prevalent nephropathy in laboratory mice.
  • MKPV-induced nephropathy serves as a valuable model for investigating tubulointerstitial fibrosis mechanisms.
  • This model shares molecular similarities with human chronic kidney disease, offering insights into human renal pathology.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
733
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
661
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
476
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
395
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
874
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.3K